Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-11-09 to 2023-12-01
Current total value of award: $18727.5
Description: 4562774324!ATEZOLIZMAB 60MG/ML 1S